As shown in Fig. 6O and S6H, I, high expression of both COX5A and AURKA significantly predicts poor relapse free survival (RFS) in breast cancer patients (HR = 2.400, log-rank p < 0.001, Fig. 6O). Here, AURKA is linked to breast carcinoma.